Product Images Amlodipine Besylate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Amlodipine Besylate NDC 43353-691 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle Label 5mg - 43353 684 60

Bottle Label 5mg - 43353 684 60

This is a medication called Amlodipine Besylate available in a pack of 90 tablets. The tablets contain 5mg of the medication. The medication code, NoC# is 5308480.*

Bottle Label 10mg - 43353 691 60

Bottle Label 10mg - 43353 691 60

Aphena Pharma Solutions - TN - Aphena

Aphena Pharma Solutions - TN - Aphena

This is an image of the structural formula for Amlodipine Besylate. - amlodusp 1

This is an image of the structural formula for Amlodipine Besylate. - amlodusp 1

Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - amlodusp 2

Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - amlodusp 2

This appears to be output from a statistical analysis, likely based on medical data. The main information provided includes an event rate of 0.0, a p-value of 0.003, and a hazard ratio of 0.691, which corresponds to a 95% confidence interval between 0.54 and 0.88. There are also two sets of values (1318, 1250, 1193 and 1157, 1130, 1098, 1066, 1039, 594) and a label "Amlodipine" which may be related to a specific medication or treatment. The chart at the bottom includes a time axis in months and may correspond to the duration of the study or the time until the event occurred. Additional context is needed to interpret this data accurately.*

Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - amlodusp 3

Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - amlodusp 3

This appears to be a table or chart for a study comparing the effects of Amlodipine and Placebo on patients with certain characteristics such as age, gender, blood pressure, vessel disease, stenosis, and stent placement. It includes the number of patients in each group and their hazard ratio for the treatment. However, without more context or the full study, it is difficult to provide a complete description.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.